Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium.
Standard
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. / Gaudet, Mia M; Milne, Roger L; Cox, Angela; Camp, Nicola J; Goode Ellen, L; Humphreys, Manjeet K; Dunning, Alison M; Morrison, Jonathan; Giles, Graham G; Severi, Gianluca; Baglietto, Laura; English, Dallas R; Couch, Fergus J; Olson, Janet E; Wang, Xianshu; Jenny, Chang-Claude; Flesch-Janys, Dieter; Abbas, Sascha; Salazar, Ramona; Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Lindblom, Annika; Margolin, Sara; Heikkinen, Tuomas; Kämpjärvi, Kati; Aaltonen, Kirsimari; Nevanlinna, Heli; Bogdanova, Natalia; Coinac, Irina; Schürmann, Peter; Dörk, Thilo; Bartram, Claus R; Schmutzler, Rita K; Tchatchou, Sandrine; Burwinkel, Barbara; Brauch, Hiltrud; Torres, Diana; Hamann, Ute; Justenhoven, Christina; Ribas, Gloria; Arias, José I; Benitez, Javier; Bojesen, Stig E; Nordestgaard, Børge G; Flyger, Henrik L; Peto, Julian; Fletcher, Olivia; Johnson, Nichola; Isabel, Dos Santos Silva; Fasching, Peter A; Beckmann, Matthias W; Strick, Reiner; Ekici, Arif B; Broeks, Annegien; Schmidt, Marjanka K; Leeuwen, van; Flora, E; Veer, Van't; Laura, J; Southey, Melissa C; Hopper, John L; Apicella, Carmel; Haiman, Christopher A; Henderson, Brian E; Loic, Le Marchand; Kolonel, Laurence N; Kristensen, Vessela; Grethe, Grenaker Alnaes; Hunter, David J; Kraft, Peter; Cox, David G; Hankinson, Susan E; Seynaeve, Caroline; Vreeswijk, Maaike P G; Tollenaar, Rob A E M; Devilee, Peter; Chanock, Stephen; Lissowska, Jolanta; Brinton, Louise; Peplonska, Beata; Czene, Kamila; Hall, Per; Li, Yuqing; Liu, Jianjun; Balasubramanian, Sabapathy; Rafii, Saeed; Reed, Malcolm W R; Pooley, Karen A; Conroy, Don; Baynes, Caroline; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun; Shen, Chen-Yang; Wang, Hui-Chun; Yu, Jyh-Cherng; Wu, Pei-Ei; Anton-Culver, Hoda; Ziogoas, Argyrios; Egan, Kathleen; Newcomb, Polly; Titus-Ernstoff, Linda; Amy, Trentham Dietz; Sigurdson, Alice J; Alexander, Bruce H; Bhatti, Parveen; Allen-Brady, Kristina; Cannon-Albright, Lisa A; Wong, Jathine; Chenevix-Trench, Georgia; Spurdle, Amanda B; Beesley, Jonathan; Pharoah, Paul D P; Easton, Doug F; Garcia-Closas, Montserrat.
in: CANCER EPIDEM BIOMAR, Jahrgang 18, Nr. 5, 5, 2009, S. 1610-1616.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium.
AU - Gaudet, Mia M
AU - Milne, Roger L
AU - Cox, Angela
AU - Camp, Nicola J
AU - Goode Ellen, L
AU - Humphreys, Manjeet K
AU - Dunning, Alison M
AU - Morrison, Jonathan
AU - Giles, Graham G
AU - Severi, Gianluca
AU - Baglietto, Laura
AU - English, Dallas R
AU - Couch, Fergus J
AU - Olson, Janet E
AU - Wang, Xianshu
AU - Jenny, Chang-Claude
AU - Flesch-Janys, Dieter
AU - Abbas, Sascha
AU - Salazar, Ramona
AU - Mannermaa, Arto
AU - Kataja, Vesa
AU - Kosma, Veli-Matti
AU - Lindblom, Annika
AU - Margolin, Sara
AU - Heikkinen, Tuomas
AU - Kämpjärvi, Kati
AU - Aaltonen, Kirsimari
AU - Nevanlinna, Heli
AU - Bogdanova, Natalia
AU - Coinac, Irina
AU - Schürmann, Peter
AU - Dörk, Thilo
AU - Bartram, Claus R
AU - Schmutzler, Rita K
AU - Tchatchou, Sandrine
AU - Burwinkel, Barbara
AU - Brauch, Hiltrud
AU - Torres, Diana
AU - Hamann, Ute
AU - Justenhoven, Christina
AU - Ribas, Gloria
AU - Arias, José I
AU - Benitez, Javier
AU - Bojesen, Stig E
AU - Nordestgaard, Børge G
AU - Flyger, Henrik L
AU - Peto, Julian
AU - Fletcher, Olivia
AU - Johnson, Nichola
AU - Isabel, Dos Santos Silva
AU - Fasching, Peter A
AU - Beckmann, Matthias W
AU - Strick, Reiner
AU - Ekici, Arif B
AU - Broeks, Annegien
AU - Schmidt, Marjanka K
AU - Leeuwen, van
AU - Flora, E
AU - Veer, Van't
AU - Laura, J
AU - Southey, Melissa C
AU - Hopper, John L
AU - Apicella, Carmel
AU - Haiman, Christopher A
AU - Henderson, Brian E
AU - Loic, Le Marchand
AU - Kolonel, Laurence N
AU - Kristensen, Vessela
AU - Grethe, Grenaker Alnaes
AU - Hunter, David J
AU - Kraft, Peter
AU - Cox, David G
AU - Hankinson, Susan E
AU - Seynaeve, Caroline
AU - Vreeswijk, Maaike P G
AU - Tollenaar, Rob A E M
AU - Devilee, Peter
AU - Chanock, Stephen
AU - Lissowska, Jolanta
AU - Brinton, Louise
AU - Peplonska, Beata
AU - Czene, Kamila
AU - Hall, Per
AU - Li, Yuqing
AU - Liu, Jianjun
AU - Balasubramanian, Sabapathy
AU - Rafii, Saeed
AU - Reed, Malcolm W R
AU - Pooley, Karen A
AU - Conroy, Don
AU - Baynes, Caroline
AU - Kang, Daehee
AU - Yoo, Keun-Young
AU - Noh, Dong-Young
AU - Ahn, Sei-Hyun
AU - Shen, Chen-Yang
AU - Wang, Hui-Chun
AU - Yu, Jyh-Cherng
AU - Wu, Pei-Ei
AU - Anton-Culver, Hoda
AU - Ziogoas, Argyrios
AU - Egan, Kathleen
AU - Newcomb, Polly
AU - Titus-Ernstoff, Linda
AU - Amy, Trentham Dietz
AU - Sigurdson, Alice J
AU - Alexander, Bruce H
AU - Bhatti, Parveen
AU - Allen-Brady, Kristina
AU - Cannon-Albright, Lisa A
AU - Wong, Jathine
AU - Chenevix-Trench, Georgia
AU - Spurdle, Amanda B
AU - Beesley, Jonathan
AU - Pharoah, Paul D P
AU - Easton, Doug F
AU - Garcia-Closas, Montserrat
PY - 2009
Y1 - 2009
N2 - Previous studies have suggested that minor alleles for ERCC4 rs744154, TNF rs361525, CASP10 rs13010627, PGR rs1042838, and BID rs8190315 may influence breast cancer risk, but the evidence is inconclusive due to their small sample size. These polymorphisms were genotyped in more than 30,000 breast cancer cases and 30,000 controls, primarily of European descent, from 30 studies in the Breast Cancer Association Consortium. We calculated odds ratios (OR) and 95% confidence intervals (95% CI) as a measure of association. We found that the minor alleles for these polymorphisms were not related to invasive breast cancer risk overall in women of European descent: ECCR4 per-allele OR (95% CI) = 0.99 (0.97-1.02), minor allele frequency = 27.5%; TNF 1.00 (0.95-1.06), 5.0%; CASP10 1.02 (0.98-1.07), 6.5%; PGR 1.02 (0.99-1.06), 15.3%; and BID 0.98 (0.86-1.12), 1.7%. However, we observed significant between-study heterogeneity for associations with risk for single-nucleotide polymorphisms (SNP) in CASP10, PGR, and BID. Estimates were imprecise for women of Asian and African descent due to small numbers and lower minor allele frequencies (with the exception of BID SNP). The ORs for each copy of the minor allele were not significantly different by estrogen or progesterone receptor status, nor were any significant interactions found between the polymorphisms and age or family history of breast cancer. In conclusion, our data provide persuasive evidence against an overall association between invasive breast cancer risk and ERCC4 rs744154, TNF rs361525, CASP10 rs13010627, PGR rs1042838, and BID rs8190315 genotypes among women of European descent.
AB - Previous studies have suggested that minor alleles for ERCC4 rs744154, TNF rs361525, CASP10 rs13010627, PGR rs1042838, and BID rs8190315 may influence breast cancer risk, but the evidence is inconclusive due to their small sample size. These polymorphisms were genotyped in more than 30,000 breast cancer cases and 30,000 controls, primarily of European descent, from 30 studies in the Breast Cancer Association Consortium. We calculated odds ratios (OR) and 95% confidence intervals (95% CI) as a measure of association. We found that the minor alleles for these polymorphisms were not related to invasive breast cancer risk overall in women of European descent: ECCR4 per-allele OR (95% CI) = 0.99 (0.97-1.02), minor allele frequency = 27.5%; TNF 1.00 (0.95-1.06), 5.0%; CASP10 1.02 (0.98-1.07), 6.5%; PGR 1.02 (0.99-1.06), 15.3%; and BID 0.98 (0.86-1.12), 1.7%. However, we observed significant between-study heterogeneity for associations with risk for single-nucleotide polymorphisms (SNP) in CASP10, PGR, and BID. Estimates were imprecise for women of Asian and African descent due to small numbers and lower minor allele frequencies (with the exception of BID SNP). The ORs for each copy of the minor allele were not significantly different by estrogen or progesterone receptor status, nor were any significant interactions found between the polymorphisms and age or family history of breast cancer. In conclusion, our data provide persuasive evidence against an overall association between invasive breast cancer risk and ERCC4 rs744154, TNF rs361525, CASP10 rs13010627, PGR rs1042838, and BID rs8190315 genotypes among women of European descent.
M3 - SCORING: Zeitschriftenaufsatz
VL - 18
SP - 1610
EP - 1616
JO - CANCER EPIDEM BIOMAR
JF - CANCER EPIDEM BIOMAR
SN - 1055-9965
IS - 5
M1 - 5
ER -